Try our Advanced Search for more refined results
March 26, 2021
SUPERNUS PHARMACEUTICALS, INC. v. AJANTA PHARMA LIMITED et al
Case Number:
3:21-cv-06964
Court:
Nature of Suit:
Patent - Abbreviated New Drug Application(ANDA)
Judge:
Firms
Companies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
January 31, 2024
Supernus Wins Ban On Generic Seizure Treatment
A New Jersey federal judge has handed a win to Supernus Pharmaceuticals Inc. in its bid to bar a competitor from being able to market a generic version of a seizure drug called Trokendi XR for the time being.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login